A randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery ("NEWTON-CABG")

Project: Research

Project Details

Project Description

Multi-center, double-blind, randomized, placebo-controlled, parallel group study of evolocumab added to statin therapy for 24 months post-operatively in a broad population of patients undergoing CABG surgery.
Short titleNEWTON-CABG
StatusFinished
Effective start/end date22/03/21 → 8/06/24

Funding

  • Unity Health Toronto

Keywords

  • cabg
  • saphenous vein graft
  • lipid
  • statin
  • cholesterol